AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 280: E788-E796, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steil, G. M.
Right arrow Articles by Weir, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steil, G. M.
Right arrow Articles by Weir, G. C.
Vol. 280, Issue 5, E788-E796, May 2001

Adaptation of beta -cell mass to substrate oversupply: enhanced function with normal gene expression

Garry M. Steil, Nitin Trivedi, Jean-Christophe Jonas, Wendy M. Hasenkamp, Arun Sharma, Susan Bonner-Weir, and Gordon C. Weir

Section of Islet Transplantation and Cell Biology, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215

Although type 2 diabetes mellitus is associated with insulin resistance, many individuals compensate by increasing insulin secretion. Putative mechanisms underlying this compensation were assessed in the present study by use of 4-day glucose (GLC; 35% Glc, 2 ml/h) and lipid (LIH; 10% Intralipid + 20 U/ml heparin; 2 ml/h) infusions to rats. Within 2 days of beginning the infusion of either lipid or glucose, plasma glucose profiles were normalized (relative to saline-infused control rats; SAL; 0.45% 2 ml/h). During glucose infusion, plasma glucose was maintained in the normal range by an approximately twofold increase in plasma insulin and an ~80% increase in beta -cell mass. During LIH infusion, glucose profiles were also maintained in the normal range. Plasma insulin responses during feeding were doubled, and beta -cell mass increased 54%. For both groups, the increase in beta -cell mass was associated with increased beta -cell proliferation (98% increase during GLC and 125% increase during LIH). At the end of the 4-day infusions, no significant changes were observed in islet-specific gene transcription (i.e., the expression of islet hormone genes, glucose metabolism genes, and insulin transcription factors were unaffected). Two days after termination of the infusions, the glucose-stimulated plasma insulin response was increased ~67% in glucose-infused animals. No sustained effect on insulin secretory capacity was observed in the LIH animals. The increase in plasma insulin response after glucose infusion was achieved in the absence of any change in insulin clearance. We conclude that, in rats, an increase in insulin demand after an increase in glucose appearance or free fatty acid leads to an increase in beta -cell mass, mediated in part by an increase in beta -cell proliferation, and that these compensatory changes lead to increased insulin secretion, normal plasma glucose levels, and the maintenance of normal islet gene expression.

insulin resistance; insulin secretion; beta -cell; mitosis; maturity onset diabetes of the young


This article has been cited by other articles:


Home page
J EndocrinolHome page
T C. Brelje, N. V Bhagroo, L. E Stout, and R. L Sorenson
Beneficial effects of lipids and prolactin on insulin secretion and {beta}-cell proliferation: a role for lipids in the adaptation of islets to pregnancy
J. Endocrinol., May 1, 2008; 197(2): 265 - 276.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. K. Hagman, M. G. Latour, S. K. Chakrabarti, G. Fontes, J. Amyot, C. Tremblay, M. Semache, J. A. Lausier, V. Roskens, R. G. Mirmira, et al.
Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets
Diabetes, February 1, 2008; 57(2): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Yokoe, L. C. Alonso, L. C. Romano, T. C. Rosa, Robert. M. O'Doherty, A. Garcia-Ocana, K. Minoguchi, and C. P. O'Donnell
Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic {beta}-cell replication in mice
J. Physiol., February 1, 2008; 586(3): 899 - 911.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al.
Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo
Diabetes, December 1, 2007; 56(12): 2927 - 2937.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. C. Alonso, T. Yokoe, P. Zhang, D. K. Scott, S. K. Kim, C. P. O'Donnell, and A. Garcia-Ocana
Glucose Infusion in Mice: A New Model to Induce {beta}-Cell Replication
Diabetes, July 1, 2007; 56(7): 1792 - 1801.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Xu, H. Kaneto, D. R. Laybutt, V. F. Duvivier-Kali, N. Trivedi, K. Suzuma, G. L. King, G. C. Weir, and S. Bonner-Weir
Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia: Possible Contribution to Impaired Incretin Effects in Diabetes
Diabetes, June 1, 2007; 56(6): 1551 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
V. ABLAMUNITS, N. A. SHERRY, J. A. KUSHNER, and K. C. HEROLD
Autoimmunity and beta Cell Regeneration in Mouse and Human Type 1 Diabetes: The Peace Is Not Enough
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 19 - 32.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. E. Panteleon, M. Loutseiko, G. M. Steil, and K. Rebrin
Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system.
Diabetes, July 1, 2006; 55(7): 1995 - 2000.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. C. Martinez, C. Cras-Meneur, E. Bernal-Mizrachi, and M. A. Permutt
Glucose Regulates Foxo1 Through Insulin Receptor Signaling in the Pancreatic Islet {beta}-cell
Diabetes, June 1, 2006; 55(6): 1581 - 1591.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Papadopoulou and H. Edlund
Attenuated Wnt Signaling Perturbs Pancreatic Growth but Not Pancreatic Function
Diabetes, October 1, 2005; 54(10): 2844 - 2851.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. C. Weir and S. Bonner-Weir
Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes
Diabetes, December 1, 2004; 53(suppl_3): S16 - S21.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Schuit, D. Flamez, A. De Vos, and D. Pipeleers
Glucose-Regulated Gene Expression Maintaining the Glucose-Responsive State of {beta}-Cells
Diabetes, December 1, 2002; 51(90003): S326 - 332.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Srinivasan, E. Bernal-Mizrachi, M. Ohsugi, and M. A. Permutt
Glucose promotes pancreatic islet beta -cell survival through a PI 3-kinase/Akt-signaling pathway
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E784 - E793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Laybutt, A. Sharma, D. C. Sgroi, J. Gaudet, S. Bonner-Weir, and G. C. Weir
Genetic Regulation of Metabolic Pathways in beta -Cells Disrupted by Hyperglycemia
J. Biol. Chem., March 22, 2002; 277(13): 10912 - 10921.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online